SERVICES

HISTORICAL BUY-SIDE MANDATES – Healthcare

Blue River

Listed below are Blue River’s historical acquisition projects for Healthcare

Healthcare and Life Sciences – A nationally recognized consulting partner for healthcare, science/technology, and higher education facilities is actively seeking equity partnerships with organizations that provide laboratory consulting/planning or equipment procurement services, especially those with experience providing technology or integrated solutions.

Key Investment Criteria:

Offerings of Interest: Laboratory Planning, Laboratory Consulting, Equipment Procurement, Lab Digital Technology Consulting.
End Markets Served: Healthcare, Cleanrooms for Large Data Companies, Universities, Municipalities / Government.
Geography: United States, Canada.
Financial Profile: At least $500K in EBITDA.

Medical Equipment Service Providers – PE firm seeks biomedical/lab equipment service firms.

Key Investment Criteria:

Offerings of Interest: Maintenance, repair, consumables, parts, equipment (biomedical/lab)
End Markets Served: Healthcare providers and labs
Geography: United States
Financial Profile: EBITDA ≥ $2MM, Revenue $20MM–$50MM

Clinical Trial Sites – PE-backed firm seeks complex trial site partnerships.

Key Investment Criteria:

Offerings of Interest: Clinical trial sites focused on complex trials
End Markets Served: Biopharma & clinical research
Geography: United States

Medical Communications – Full-service med comms firm seeks synergistic acquisitions.

Key Investment Criteria:

Offerings of Interest: Med comms, publications, speaker bureau, HCP engagement & education
End Markets Served: Biopharmaceutical companies
Geography: United States, Canada
Financial Profile: EBITDA > $1MM

Production, Training & Tech Solutions – Agency seeks synergistic acquisitions.

Key Investment Criteria:

Offerings of Interest: Training, patient/provider education, digital learning, event production
End Markets Served: Biopharma & life sciences companies
Geography: United States

Healthcare Marketing Agency – PE-backed agency seeks strategic acquisitions.

Key Investment Criteria:

Offerings of Interest: Med comms, PR, boutique advertising
End Markets Served: Pharmaceutical industry
Geography: United States

Vitamin, Mineral, Supplement Co. – PE group seeks VMS platform investment.

Key Investment Criteria:

Offerings of Interest: VMS, contract manufacturing, distribution, MLM
End Markets Served: Health & wellness
Geography: North America
Financial Profile: EBITDA ≥ $3MM

Clinical Research Organization (CRO) – Canadian CRO seeks U.S. acquisitions.

Key Investment Criteria:

Offerings of Interest: Full-service CRO with strategic alignment
End Markets Served: Life sciences, pharma
Geography: United States
Financial Profile: Revenue $10MM–$50MM

Obesity-Related Products or Services – PE group seeks obesity-related platform.

Key Investment Criteria:

Offerings of Interest: Nutraceuticals, bariatric tools, home health, weight loss
End Markets Served: Health & wellness
Geography: United States, Canada
Financial Profile: Revenue ≥ $20MM, EBITDA ≥ $3.5MM

Prosthetics/Medical Device Manufacturer – Global science/tech firm seeks expansion.

Key Investment Criteria:

Offerings of Interest: Prosthetics, medical devices (e.g. knee/hip replacements)
End Markets Served: Medical device sector
Geography: United States, Canada, Europe
Financial Profile: Revenue $3MM–$75MM

Revenue Cycle Management – Leading PE firm seeks U.S./Canada based RCM firm.

Key Investment Criteria:

Offerings of Interest: Revenue cycle management services
End Markets Served: Healthcare systems
Geography: United States, Canada
Financial Profile: Revenue ≥ $20MM, EBITDA ≥ $3.5MM

Medical Device Manufacturing – PE group seeks medical device platform.

Key Investment Criteria:

Offerings of Interest: Home health equipment, surgical instruments, monitoring equipment
End Markets Served: Healthcare industry
Geography: United States
Financial Profile: EBITDA ≥ $4MM

Clinical Research Organization (CRO) – U.S. CRO seeks aligned pharma service firms. Imperial Clinical Research – 2009-2010

Key Investment Criteria:

Offerings of Interest: Pharma CRO, patient recruitment, medical translation
End Markets Served: Pharmaceutical R&D
Geography: United States
Financial Profile: Revenue $3MM–$15MM

Sara Clevenger, Partner & Buy-Side Practice Leader, provides strategic direction and oversight for the firm’s Acquisition Support Investment Banking Group. Ms. Clevenger brings over 15 years of experience in Corporate Development, Mergers & Acquisitions, Commercial Real Estate Development, Portfolio and Transaction Management. Sara’s full bio is available here.

M: (412) 916-5026
O: (248) 309-3730 ext. 306
E: sclevenger@goblueriver.com